Table 1.
Clinicopathological features of 15 early and 25 late HBV-related HCC
| Feature | Early HCC (n = 15) | Late HCC (n = 25) |
|---|---|---|
| Sex | ||
| Male |
13 (87 %) |
21 (84 %) |
| Female |
2 (13 %) |
4 (16 %) |
| AgeA |
53.67 ± 10.80 |
53.40 ± 12.59 |
| AFP(ng/mL)A |
629.07 ± 561.23 |
56682.04 ± 6704.74 |
| Tumor size(cm)A,B |
2.33 ± 0.48 |
10.84 ± 3.04 |
| Venous invasion | ||
| Absent |
15 (100 %) |
18 (72 %) |
| Present |
0 (0) |
7 (28 %) |
| Microsatlite lesion | ||
| Absent |
15 (100 %) |
16 (64 %) |
| Present |
0 (0) |
9 (36 %) |
| Liver function | ||
| Grade A |
15 (100 %) |
14 (56 %) |
| Grade B |
0 (0) |
11 (44 %) |
| Grade C |
0 (0) |
0 (0) |
| Tumor stage (AJCC) | ||
| Stage I |
15 (100 %) |
0 (0) |
| Stage II |
0 (0) |
12 (48 %) |
| Stage IIIA&B | 0 (0) | 13 (52 %) |
A Mean ± SD.
B Measured by the length of the largest tumor nodule.
cChild-pugh classification.
AFP, Alpha Fetoprotein; AJCC, AJCC, The American Joint Committee on Cancer.